Updates in Developing Effective Biomarker Strategies for CAR-T Therapies

• Showcasing progress in CAR-T for hematologic malignancies
• Reviewing updates and innovation in CAR-T for solid tumors
• Exploring updates on prognostic and predictive biomarkers

Speakers:

Ivan Horak

Founder & Chief Executive Officer

Tikva Allocell